MicuRx Pharmaceuticals Lands $55,000,000 Series C Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b7f6148-61b0-4c17-bfa6-7b80894287fe
Date
9/28/2016
Company Name
MicuRx Pharmaceuticals
Mailing Address
3916 Trust Way Hayward, CA 94545 USA
Company Description
MicuRx is discovering and developing next-generation antibacterial andantifungal products. By making specific modifications to validatedantibiotics, MicuRx intends to improve overall pharmacological propertiesof antimicrobial drugs in order to overcome antibiotic resistance.
Website
http://www.micurx.com
Transaction Type
Venture Equity
Transaction Amount
$55,000,000
Transaction Round
Series C
Proceeds Purposes
Funding from Series C financing will be used to continue development of MRX-I in both the United States and China.
M&A Terms
Venture Investor
GP Capital
Venture Investor
3E Bioventures
Venture Investor
Delin Capital